Home » Topics » BioWorld Science

BioWorld Science
RSS

MTD of seliciclib defined at 400 mg for rheumatoid arthritis refractory to TNF blockade

March 30, 2021

Daiichi Sankyo compound inhibits G9a/GLP to induce fetal hemoglobin production

March 30, 2021

IFI27L2A is elevated in microglial cells after stroke

March 30, 2021

Arenobufagin derivative ZM-226 has antitumor activity with low cardiotoxicity

March 30, 2021

First subject dosed in phase I study of Gritstone's second-generation COVID-19 vaccine

March 30, 2021

Mission Therapeutics discovers USP30 inhibitors

March 30, 2021

Intra-Cellular Therapies identifies new phosphodiesterase PDE1 inhibitors

March 30, 2021

New platinum IV complexes synthesized at VUAB Pharma

March 30, 2021

Inflazome divulges new NLRP3 inflammasome inhibitors

March 30, 2021

Adagene reports interim data from ongoing phase I study of ADG-116

March 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...